Linkerbot, a Dexterous Robotic Hand Company, Considers Hong Kong IPO as Early as This Year

According to Bloomberg, Linkerbot, a Chinese dexterous hand startup, is considering an IPO in Hong Kong, which could be completed as early as this year. Sources familiar with the matter revealed that the company has appointed CMB International, CITIC Securities, and HSBC as sponsors for the listing. If the process proceeds smoothly, the fundraising scale is expected to reach hundreds of millions of dollars.

Dexterous hands are a crucial link in the transition of humanoid robots from demonstration to industrial application. Whether robots can truly be implemented in complex manufacturing workstations hinges on whether they possess both precise manipulation capabilities and stable industrial load capacity. After CES 2026 in Las Vegas in January this year, Linkerbot stated that its Linker Hand product can complete delicate tasks such as threading a needle and also bear heavy industrial loads. The company also claims that its market share in the global high-degree-of-freedom dexterous hand market exceeds 80%.

The imagination space on the demand side comes from the industrialization of the humanoid robot industry. Elon Musk once pointed out that hands are one of the most difficult parts to manufacture in humanoid robots; China is also accelerating the promotion of related applications, with Shanghai proposing to deploy 100,000 humanoid robots in manufacturing by 2030. If humanoid robots enter the mass production and factory deployment stage, dexterous hands will become a key component determining their application boundaries.

The popularity of the robotics theme has already been reflected in the performance of new stocks. The stock price of industrial robot company EFORT soared nearly doubled on its first day of listing on Monday, with the public offering portion oversubscribed by 14,800 times. Beijing Galbot and Shanghai ZHIYUAN Robotics are also preparing for listing in Hong Kong. Linkerbot just completed a RMB 1.5 billion Series B financing round in February this year, with investors including Daode Investment, Shengshi Capital, and Singapore's Eastern Epic Capitals.